NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/13/2024
Back to search
Official data from USPTO
MORTAZAVI CLINIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
08/13/2024
Trademark type
Combined
Nice classes
44
Filing date
06/13/2022
Registration date
08/13/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/13/2024
Last transaction
08/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/01/2022
First use in commerce
11/01/2022
Drawing code
3
Owner type
01
Owner location
West Hollywood, CA, US
Examiner
SIMCOX,KYLE DUNCAN
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "MORTAZAVI CLINIC" in blue below the design of a blue heart formed by curved lines. The color white in the mark represents background or transparent areas and is not a feature of the mark.
Holders and representatives
Holders
Mortazavi, Martin
Representatives
Javier Gomez MARKAVO.COM
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Hospital services for persons with physical and/or cognitive disabilities or impairments; medical assistance consultancy provided by doctors and other specialized medical personnel; individual medical counseling services provided to patients
Publications
History of USPTO decisions and trademark events.
35 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/13/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/08/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/08/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/06/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/06/2024
IUAF
USE AMENDMENT FILED
05/28/2024
EISU
TEAS STATEMENT OF USE RECEIVED
05/28/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/28/2023
DOCK
ASSIGNED TO EXAMINER
11/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/03/2023
PUBO
PUBLISHED FOR OPPOSITION
10/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/13/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/28/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
08/28/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/28/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
08/28/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/28/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/23/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/23/2023
ALIE
ASSIGNED TO LIE
08/23/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/11/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/11/2023
GNSL
LETTER OF SUSPENSION E-MAILED
04/11/2023
CNSL
SUSPENSION LETTER WRITTEN
04/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/27/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/27/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/27/2023
GNRT
NON-FINAL ACTION E-MAILED
03/27/2023
CNRT
NON-FINAL ACTION WRITTEN
03/27/2023
DOCK
ASSIGNED TO EXAMINER
03/26/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/24/2022
NWAP
NEW APPLICATION ENTERED
06/16/2022
Continuous trademark protection
Get notified about every new filing that threatens MORTAZAVI CLINIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.